You are here
Clinical Trials: Myocardial Ischemia
Each Clinical Trial will open in a new browser window or tab.
Conditions: Diabetes Mellitus; Ischemic Heart Disease
Interventions: Drug: 100 million Allogeneic Mesenchymal Human Stem Cells; Other: Placebo
Sponsors: Joshua M Hare; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Interventions: Drug: 100 million Allogeneic Mesenchymal Human Stem Cells; Other: Placebo
Sponsors: Joshua M Hare; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
Conditions: Myocardial Infarction; Heart Diseases
Intervention: Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Intervention: Device: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto
Not yet recruiting
Condition: Acute Myocardial Infarction
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Interventions: Biological: Intravenous infusion placebo; Biological: Intravenous infusion WJMSCs
Sponsors: Navy General Hospital, Beijing; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital; Chinese PLA General Hospital
Not yet recruiting
Condition: Coronary Artery Disease
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Intervention: Biological: Intravenous infusion human umbilical Wharton's jelly-derived mesenchymal stem Cell or placebo PBS
Sponsors: Navy General Hospital, Beijing; Chinese PLA General Hospital; Peking University Third Hospital; Peking Union Medical College Hospital; Xijing Hospital
Not yet recruiting
Condition: Respiratory Tract Diseases
Intervention: Drug: Stem Cell Product
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Intervention: Drug: Stem Cell Product
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Intervention: Biological: Mesenchymal Stem Cells
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Condition: Heart Attack
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Intervention: Drug: PEP in Acute Myocardial Infarction
Sponsor: Paul G. Stalboerger
Not yet recruiting
Condition: Acute Myocardial Infarction
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
Intervention: Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Recruiting
Condition: Coronary Artery Disease
Intervention: Biological: MCRcI® stem cells
Sponsors: Honya Medical Inc; Chang Gung Memorial Hospital
Recruiting
Intervention: Biological: MCRcI® stem cells
Sponsors: Honya Medical Inc; Chang Gung Memorial Hospital
Recruiting
Condition: Myocardial Infarction
Intervention: Biological: MiSaver®
Sponsors: Honya Medical Inc; Chung Shan Medical University
Recruiting
Intervention: Biological: MiSaver®
Sponsors: Honya Medical Inc; Chung Shan Medical University
Recruiting
